FUNCTIONS OF ATP-BINDING CASSETTE (ABC) TRANSPORTERS
DOI:
https://doi.org/10.56782/pps.85Keywords:
ATP–binding cassette [ABC] transporters, P–glycoproteinAbstract
Several types of transporters present in the body control the fate of drugs by affecting uptake, distribution, and elimination processes. Among other functions, these proteins mediate the influx and efflux of endogenous as well as exogenous substances across the membranes of the small intestine, bile duct, and blood-brain barrier. In polypharmacotherapy, ATP–dependent transporters (ATP–binding cassette [ABC] transporters) expressed on the apical membrane of intestinal epithelial cells determine oral bioavailability, intestinal efflux clearance, and drug–drug interactions of certain xenobiotics. P-glycoprotein (Pgp), product of the human MDR1 gene, is one of the most important proteins belonging to the ABC transporter superfamily. The tissue and organ distribution of Pgp significantly affects the uptake of xenobiotics, and interactions of drugs with this protein may alter bioavailability of other drugs that are administered simultaneously. The subfamilies of ATP–dependent efflux transporters are discussed, with emphasis on their functions.
Downloads
References
Jones, P.M., George, A.M. „The ABC transporter structure and mechanism: perspectives on recent research”, Cellular and Molecular Life Sciences, 2004, 61, 682-699 DOI: https://doi.org/10.1007/s00018-003-3336-9
Schneider, E., Hunke, S. „ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolizing subunits/domains”, Microbiology Reviews, 1998, 22, 1-20 DOI: https://doi.org/10.1111/j.1574-6976.1998.tb00358.x
Dean, M., Rzhetsky, A., Allikmets, R. „The Human ATP-Binding Cassette (ABC) Transporter Superfamily”, Genome Research, 2001, 11, 1156-1166 DOI: https://doi.org/10.1101/gr.184901
Kast, C., Canfield, V., Levenson, R., Gros, P. „Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence”, Journal of Biological Chemistry, 1996, 271 (16), 9240-9248 DOI: https://doi.org/10.1074/jbc.271.16.9240
Bianchet, M.A, Ko, Y.H., Amzel, M., Pedersen, P.L. „Modeling of nucleotide binding domains of ABC transporter proteins based on F1-ATPase/recA topology: Structural model of the nucleotide binding domains of cystic fibrosis transmembrane conductance regulator (CFTR)”, Journal of Bioenergetics and Biomembranes, 1997,29 (5),503-524 DOI: https://doi.org/10.1023/A:1022443209010
Czajka-Uhryn, M., Bednarek, I. „Interferencja RNA – nowe narzędzie molekularne w modulacji zjawiska oporności wielolekowej”, Annales Academiae Medicae Silesiensis, 2005,59 (3), 209-218
Doyle, L.A., Ross, D.D. „Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)”, Oncogene, 2003,22,7340-7358 DOI: https://doi.org/10.1038/sj.onc.1206938
Oswald, C., Holland, I.B., Schmitt, L. „The motor domains of ABC-transporters: What can structure tell us?”, Naunyn-Schmiedeberg’s Archives of Pharmacology, 2006, 372 (6), 385-399 DOI: https://doi.org/10.1007/s00210-005-0031-4
Backer, J., Depret, G., Van Bambeke, F., Tulkens, P., Prevost, M. „Molecular models of human P-glycoprotein in two different catalytic states”, BMC Structural Biology , 2009, 9 (3), 1-18
Hennessy, M., Spiers, J. „A primer on the mechanistic of P-glycoprotein the multidrug transporter”. Pharmacological Research, 2007, 55, 1- 15. DOI: https://doi.org/10.1016/j.phrs.2006.10.007
Raggers, R.J., Pomorski, T., Holthuis, J.C.M., Kalin, N.E., Meer, G.F.B.P.,Van. „Lipid traffic: The ABC of transbilayer movement”, Traffic, 2000,1,226-234 DOI: https://doi.org/10.1034/j.1600-0854.2000.010305.x
Germann, U.A. „P-glycoprotein – a mediator of multidrug resistance in tumor cells”, European Journal of Cancer, 1996,32A (6), 927-944 DOI: https://doi.org/10.1016/0959-8049(96)00057-3
Jamroziak, K., Młynarski, W., Robak, T. „Znaczenie białek transportowych nadrodziny ABC w oporności na leczenie ostrej białaczki szpikowej”, Acta Haematologica Polonica, 2001, 32 (2), 131-145
Nasiłowska, B. „Geny oporności na leki”, Postępy Nauk Medycznych, 2003, 3-4, 99-105
Marie, J. P. „Drug resistance and its modifications in haematological malignancies”, Degos, L., Linch, D.C., Lowenberg B. „Textbook of Malignant Haematology” 1st ed.,1999, UK, Dunitz M Ltd, 299-313
Sigmund, W., Cascobi, I., Weitschies, W., Kroemer, H.K. „Significance of drug transporter for the internal medicine clinic”, Internist, 2003, 44, 219-226 DOI: https://doi.org/10.1007/s00108-002-0784-5
Gottesman, M.M., Ling, V. „The molecular basis of multidrug resistance in cancer: The early of P-glycoprotein research”, FEBS Letters, 2006, 58, 998-1006 DOI: https://doi.org/10.1016/j.febslet.2005.12.060
Pal, D., Mitra, A.K. „MDR- and CYP3A4-mediated drug-drug interactions”, Journal of Neuroimmune Pharmacology, 2006, 1 (3), 323-339 DOI: https://doi.org/10.1007/s11481-006-9034-2
Sellig, A. „A general pattern for substrate recognition by P-glycoprotein”, European Journal of Biochemistry, 1998, 251, 252-261 DOI: https://doi.org/10.1046/j.1432-1327.1998.2510252.x
Takano, M., Yumoto, R., Murakami, T. „Expression and function of efflux drug transporters in the intestine”, Pharmacology and Therapeutics, 2006, 109, 137-161
Kerb, R. „Implications of genetic polymorphism in drug transporters for pharmacotherapy”, Cancer Letters, 2006, 234, 4-33 DOI: https://doi.org/10.1016/j.canlet.2005.06.051
Marchetti, S., Mazzanti, R., Beijnen, J.H., Schellens J.H.B. „Concise review: Clinical relevance of drug-drug and herb-drug interaction mediated by the ABC transporter ABCB1(MDR1, P-glycoprotein)”, The Oncologist, 2007,12, 927-941 DOI: https://doi.org/10.1634/theoncologist.12-8-927
Saito, T., Zhang, Z., Tokuriki, M., Ohtsubo, T., Shibamori, Y., Yamamoto, T., Saito, H. „Cyclosporin A inhibits the extrusion pump function of P-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin”, Brain Research, 2001, 265-270 DOI: https://doi.org/10.1016/S0006-8993(01)02321-6
Kim, W.Y., Benet, L.Z. „P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro”, Pharmaceutical Research, 2004, 21(7), 1284-1293 DOI: https://doi.org/10.1023/B:PHAM.0000033017.52484.81
Mangham, D.C, Cannon, A., Komiya, S., Gendron, R.L., Dunussi, K., Gebhardt, M.C., Mankin, H.J., Arceci, R.J. „P-glycoprotein is expressed in the mineralizing regions of the skeleton”, Calcified Tissue International, 1996, 58, 186-191 DOI: https://doi.org/10.1007/BF02526885
Backer, J.P., Depret, G., Van Bambeke, F., Tulkens, P.M., Prevost, M. „Molecular models of human P-glycoprotein in two different catalitic states”, BMC Structural Biology, 2009, 9 (3), 1-18 DOI: https://doi.org/10.1186/1472-6807-9-3
Haslam, I.S., Jones, K., Coleman, T., Simmons, N.L. „Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84)”, Biochemical Pharmacology, 2008, 76, 850-861 DOI: https://doi.org/10.1016/j.bcp.2008.07.020
Benet, L.Z., Cummins, C.L. „The efflux-metabolism alliance: Biochemical aspects”, Advanced Drug Delivery Reviews, 2001, 50 (1), 3-11 DOI: https://doi.org/10.1016/S0169-409X(01)00178-8
Van der Bliek, A.M., Baas, F., Ten Houte de Lange, T., Kooiman P.M., Van der Velde-Koerts, T., Borst, P. „The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver”, EMBO Journal, 1988, 6 (11), 3325–3331 DOI: https://doi.org/10.1002/j.1460-2075.1987.tb02653.x
Rosmorduc, O., Hermelin, B., Poupon, R. „MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis”, Gastroenterology, 2001, 120 (6): 1459–67 DOI: https://doi.org/10.1053/gast.2001.23947
Kim, R.B. „Transporters and Drug Delivery: Why, When and How?”, Molecular Pharmaceutics, 2005, 3 (1), 26-32 DOI: https://doi.org/10.1021/mp050084o
Quinton, P.M. „Physiological basis of cystic fibrosis: A historical perspective”, Physiological Reviews, 1999, 79, 3-22 DOI: https://doi.org/10.1152/physrev.1999.79.1.S3
Borst, P., Evers, R., Kool, M., Wijnholds, J. „A family of drug transporters: The multidrug resistance-associated proteins”, Journal of the National Cancer Institute, 2000, 92 (16), 1295-1302 DOI: https://doi.org/10.1093/jnci/92.16.1295
Takano, M., Yumoto, R., Murakami, T. „Expression and function of efflux drug transporters in the intestine”, Pharmacology and Therapeutics, 2006, 109, 137-161 DOI: https://doi.org/10.1016/j.pharmthera.2005.06.005
St-Pierre, M.V., Serrano, M.A., Macias, R.I., Dubs, U., Hoechli, M., Lauper, U. i wsp. „Expression of members of the multidrug resistance protein family in human term placenta”, American Journal of Physiology, Regulatory, Integrative and Comparative Physiology, 2000, 279, 1495-1503 DOI: https://doi.org/10.1152/ajpregu.2000.279.4.R1495
Bart, J., Hollema, H., Groen, H.J., de Vries, E.G., Hendrikse, N.H., Sleijfer, D.T. „The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2 in the normal blood-testis barrier and in primary testicular tumors”, European Journal of Cancer, 2004, 40, 2064-2070 DOI: https://doi.org/10.1016/j.ejca.2004.05.010
Kim, R.B. „Transporters and xenobiotic disposition”, Toxicology, 2002, 181-182, 291-297 DOI: https://doi.org/10.1016/S0300-483X(02)00296-2
Zeuzern, S., Welsch, C., Herrmann, E. „Pharmacokinetics of peginterferons”, Seminars in Liver Disease, 2003, 23 (1), 23-28 DOI: https://doi.org/10.1055/s-2003-41631
Klucken, J., Buchler, C., Orso, E., Kamiński, W.E., Porsch-Ozcurumez, M., Liebisch, G. I wsp. „ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport”, Proceedings of the National Academy of Science, 2000, 97 (2), 817-822 DOI: https://doi.org/10.1073/pnas.97.2.817
Breedveld, P., Beijnen, J.H., Schellens, J.H.M. „Use of P-glycoprotein and BRCP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs”, Trends in Pharmacological Sciences, 2006, 27 (1), 17-24 DOI: https://doi.org/10.1016/j.tips.2005.11.009
Miyake, K., Mickley, L., Litman, T., Zahn, Z., Robey, R., Cristensen, B. „Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Determination of homology to ABC transporters genes”, Cancer Research, 1999, 59, 8-13
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
